Published in Stroke on May 29, 2003
Heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation (2011) 31.98
Heart disease and stroke statistics--2011 update: a report from the American Heart Association. Circulation (2010) 30.07
Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2014) 3.48
Primary prevention of stroke by healthy lifestyle. Circulation (2008) 3.32
Are network-based interventions a useful antiobesity strategy? An application of simulation models for causal inference in epidemiology. Am J Epidemiol (2013) 2.20
Genetic and environmental contributions to carotid intima-media thickness and obesity phenotypes in the Northern Manhattan Family Study. Stroke (2004) 1.42
Impact of waist circumference and body mass index on risk of cardiometabolic disorder and cardiovascular disease in Chinese adults: a national diabetes and metabolic disorders survey. PLoS One (2013) 1.37
Type 2 diabetes and cognitive impairment: linking mechanisms. J Alzheimers Dis (2012) 1.28
Measures of adiposity and risk of stroke in China: a result from the Kailuan study. PLoS One (2013) 1.25
Unevenly distributed: a systematic review of the health literature about socioeconomic inequalities in adult obesity in the United Kingdom. BMC Public Health (2012) 1.15
General and abdominal adiposity and risk of stroke in Chinese women. Stroke (2009) 1.06
Race- and sex-specific associations of obesity measures with ischemic stroke incidence in the Atherosclerosis Risk in Communities (ARIC) study. Stroke (2010) 1.00
Stroke prevention: modifying risk factors. Ther Adv Cardiovasc Dis (2008) 0.99
Dietary total fat intake and ischemic stroke risk: the Northern Manhattan Study. Neuroepidemiology (2009) 0.99
Interleukin-1 and acute brain injury. Front Cell Neurosci (2015) 0.95
Vascular risk factors in the Swiss population. J Neurol (2005) 0.95
Risk factor management to prevent first stroke. Neurol Clin (2008) 0.92
Clinical significance of monocyte heterogeneity. Clin Transl Med (2015) 0.90
The neurology of enteric disease. J Neurol Neurosurg Psychiatry (2006) 0.88
A gender-stratified comparative analysis of various definitions of metabolic syndrome and cardiovascular risk in a multiethnic U.S. population. Metab Syndr Relat Disord (2011) 0.87
Relations of meeting national public health recommendations for muscular strengthening activities with strength, body composition, and obesity: the Women's Injury Study. Am J Public Health (2011) 0.86
Reductions in cardiovascular risk after bariatric surgery. Curr Opin Cardiol (2011) 0.85
Hyperglycemia and stroke mortality: comparison between fasting and 2-h glucose criteria. Diabetes Care (2008) 0.85
Thoracic periaortic and visceral adipose tissue and their cross-sectional associations with measures of vascular function. Obesity (Silver Spring) (2013) 0.84
Mechanisms of thrombosis in obesity. Curr Opin Hematol (2013) 0.84
Obesity and Subtypes of Incident Cardiovascular Disease. J Am Heart Assoc (2016) 0.83
Influence of age and health behaviors on stroke risk: lessons from longitudinal studies. J Am Geriatr Soc (2010) 0.82
Association between different obesity measures and the risk of stroke in the EPIC Spanish cohort. Eur J Nutr (2014) 0.80
Association between cytochrome P450 promoter polymorphisms and ischemic stroke. Exp Ther Med (2011) 0.80
Dietary intake alters behavioral recovery and gene expression profiles in the brain of juvenile rats that have experienced a concussion. Front Behav Neurosci (2015) 0.79
Stroke Risk Factors, Genetics, and Prevention. Circ Res (2017) 0.78
Alcohol consumption and the risk of stroke among hypertensive and overweight men. J Neurol (2012) 0.78
Nutrition, insulin resistance and dysfunctional adipose tissue determine the different components of metabolic syndrome. World J Diabetes (2016) 0.77
Ischemic Stroke and Its Risk Factors in a Registry-Based Large Cross-Sectional Diabetic Cohort in a Country Facing a Diabetes Epidemic. J Diabetes Res (2016) 0.77
Rationale for multiple risk intervention: the need to move from theory to practice. Vasc Health Risk Manag (2007) 0.77
Stopping the cardiovascular disease continuum: Focus on prevention. World J Cardiol (2010) 0.77
Body Mass Index and Decline of Cognitive Function. PLoS One (2016) 0.76
Current issues in antiplatelet therapy for stroke prevention: the importance of stroke subtypes and differences between stroke and MI patients. J Neurol (2010) 0.76
Association of high waist-to-height ratio with functional outcomes in patients with acute ischemic stroke: A report from the ACROSS-China study. Medicine (Baltimore) (2017) 0.75
Metabolic Syndrome and its Profound Effect on Prevalence of Ischemic Stroke. Am Med Stud Res J (2014) 0.75
Metabolic rehabilitation: science gathers to support a new intervention to prevent stroke. Stroke (2011) 0.75
A new synthetic matrix metalloproteinase inhibitor reduces human mesenchymal stem cell adipogenesis. PLoS One (2017) 0.75
Alcohol, Brain Derived Neurotrophic Factor and Obesity among People Living with HIV. J AIDS Clin Res (2013) 0.75
The Intricate Network of Adipokines and Stroke. Int J Endocrinol (2015) 0.75
Comparison of recovery criteria in morbidly obese patients undergoing laparoscopic gastric sleeve resection following use of sevoflurane and isoflurane. Anesth Essays Res (2015) 0.75
A new paradigm in the treatment of the cardiovascular disease continuum: focus on prevention. Hippokratia (2011) 0.75
Digestion of starch in a dynamic small intestinal model. Eur J Nutr (2015) 0.75
vWF correlates with visceral and pericardial adipose tissue in patients with a recent stroke of suspected cardiogenic etiology. PLoS One (2017) 0.75
Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 56.72
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 41.47
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 26.95
Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet (2010) 11.25
The state of US health, 1990-2010: burden of diseases, injuries, and risk factors. JAMA (2013) 10.43
Global and regional burden of stroke during 1990-2010: findings from the Global Burden of Disease Study 2010. Lancet (2014) 10.06
2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol (2014) 9.96
Short sleep duration as a risk factor for hypertension: analyses of the first National Health and Nutrition Examination Survey. Hypertension (2006) 8.72
Inadequate sleep as a risk factor for obesity: analyses of the NHANES I. Sleep (2005) 8.15
Telmisartan to prevent recurrent stroke and cardiovascular events. N Engl J Med (2008) 7.25
Warfarin and aspirin in patients with heart failure and sinus rhythm. N Engl J Med (2012) 6.60
Effect of medical treatment in stroke patients with patent foramen ovale: patent foramen ovale in Cryptogenic Stroke Study. Circulation (2002) 4.69
Sleep duration as a risk factor for diabetes incidence in a large U.S. sample. Sleep (2007) 4.14
Ischemic stroke subtype incidence among whites, blacks, and Hispanics: the Northern Manhattan Study. Circulation (2005) 4.08
Update to the AHA/ASA recommendations for the prevention of stroke in patients with stroke and transient ischemic attack. Stroke (2008) 4.06
An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2013) 3.60
Antiphospholipid antibodies and subsequent thrombo-occlusive events in patients with ischemic stroke. JAMA (2004) 3.51
Statin therapy in the prevention of recurrent cardiovascular events: a sex-based meta-analysis. Arch Intern Med (2012) 3.50
Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2014) 3.48
Periodontal microbiota and carotid intima-media thickness: the Oral Infections and Vascular Disease Epidemiology Study (INVEST). Circulation (2005) 3.25
Predicting long-term outcome after acute ischemic stroke: a simple index works in patients from controlled clinical trials. Stroke (2008) 3.21
Sodium, blood pressure, and cardiovascular disease: further evidence supporting the American Heart Association sodium reduction recommendations. Circulation (2012) 3.14
The importance of population-wide sodium reduction as a means to prevent cardiovascular disease and stroke: a call to action from the American Heart Association. Circulation (2011) 2.89
National Stroke Association guidelines for the management of transient ischemic attacks. Ann Neurol (2006) 2.82
Homocysteine and the risk of ischemic stroke in a triethnic cohort: the NOrthern MAnhattan Study. Stroke (2004) 2.76
Forecasting the future of stroke in the United States: a policy statement from the American Heart Association and American Stroke Association. Stroke (2013) 2.66
Metabolic syndrome and ischemic stroke risk: Northern Manhattan Study. Stroke (2007) 2.55
Moderate alcohol consumption reduces risk of ischemic stroke: the Northern Manhattan Study. Stroke (2005) 2.51
Ideal cardiovascular health predicts lower risks of myocardial infarction, stroke, and vascular death across whites, blacks, and hispanics: the northern Manhattan study. Circulation (2012) 2.48
Relationship between periodontal disease, tooth loss, and carotid artery plaque: the Oral Infections and Vascular Disease Epidemiology Study (INVEST). Stroke (2003) 2.45
2012 ACCF/AATS/SCAI/STS expert consensus document on transcatheter aortic valve replacement. J Am Coll Cardiol (2012) 2.44
Aortic arch plaques and risk of recurrent stroke and death. Circulation (2009) 2.40
Comparison of 30-day mortality models for profiling hospital performance in acute ischemic stroke with vs without adjustment for stroke severity. JAMA (2012) 2.38
Stroke in the young in the northern Manhattan stroke study. Stroke (2002) 2.37
Patent foramen ovale and stroke. Circulation (2005) 2.34
Traditional risk factors are not major contributors to the variance in carotid intima-media thickness. Stroke (2013) 2.34
Relation of plasma glucose and endothelial function in a population-based multiethnic sample of subjects without diabetes mellitus. Am J Cardiol (2005) 2.34
Long-term functional recovery after first ischemic stroke: the Northern Manhattan Study. Stroke (2009) 2.33
Risk of myocardial infarction or vascular death after first ischemic stroke: the Northern Manhattan Study. Stroke (2007) 2.30
Left ventricular mass and geometry and the risk of ischemic stroke. Stroke (2003) 2.15
Patent foramen ovale and the risk of ischemic stroke in a multiethnic population. J Am Coll Cardiol (2007) 2.15
Infectious burden and risk of stroke: the northern Manhattan study. Arch Neurol (2009) 2.08
Stroke literacy in Central Harlem: a high-risk stroke population. Neurology (2009) 2.06
Antithrombotic and thrombolytic therapy for ischemic stroke: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest (2008) 2.06
Clinical outcome after first and recurrent hemorrhage in patients with untreated brain arteriovenous malformation. Stroke (2006) 2.05
Insulin resistance and risk of ischemic stroke among nondiabetic individuals from the northern Manhattan study. Arch Neurol (2010) 2.00
Sleep duration associated with mortality in elderly, but not middle-aged, adults in a large US sample. Sleep (2008) 1.98
Chronic kidney disease is associated with white matter hyperintensity volume: the Northern Manhattan Study (NOMAS). Stroke (2007) 1.96
Prevalence and prognostic value of subclinical left ventricular systolic dysfunction by global longitudinal strain in a community-based cohort. Eur J Heart Fail (2014) 1.96
Tumor necrosis factor receptor levels are associated with carotid atherosclerosis. Stroke (2002) 1.94
Total homocysteine is associated with white matter hyperintensity volume: the Northern Manhattan Study. Stroke (2005) 1.91
Stroke location and association with fatal cardiac outcomes: Northern Manhattan Study (NOMAS). Stroke (2008) 1.91
Mediterranean-style diet and risk of ischemic stroke, myocardial infarction, and vascular death: the Northern Manhattan Study. Am J Clin Nutr (2011) 1.91
Our time: a call to save preventable death from cardiovascular disease (heart disease and stroke). Circulation (2012) 1.87
Aortic atherosclerosis, hypercoagulability, and stroke the APRIS (Aortic Plaque and Risk of Ischemic Stroke) study. J Am Coll Cardiol (2008) 1.85
White matter hyperintensities and subclinical infarction: associations with psychomotor speed and cognitive flexibility. Stroke (2008) 1.84
The association between endothelial dysfunction and cardiovascular outcomes in a population-based multi-ethnic cohort. Atherosclerosis (2006) 1.83
Stroke Genetics Network (SiGN) study: design and rationale for a genome-wide association study of ischemic stroke subtypes. Stroke (2013) 1.80